{"doc_id": "PMID-9715838.txt", "sent_id": "S1", "tokens": ["Inhibition", "of", "HIV-1", "replication", "by", "combination", "of", "a", "novel", "inhibitor", "of", "TNF-alpha", "with", "AZT", "."], "sentence": "Inhibition of HIV-1 replication by combination of a novel inhibitor of TNF-alpha with AZT .", "event_mentions": [{"id": "E1", "event_type": "Negative_regulation", "trigger": {"text": "inhibitor", "start": 9, "end": 9}, "arguments": [{"entity_id": "T1", "text": "TNF-alpha", "role": "Theme"}]}], "entity_mentions": [{"id": "T1", "text": "TNF-alpha", "entity_type": "Protein", "start": 11, "end": 11}, {"id": "T8", "text": "inhibitor", "entity_type": "Negative_regulation", "start": 9, "end": 9}]}
{"doc_id": "PMID-9715838.txt", "sent_id": "S2", "tokens": ["The", "small", "molecule", "S9a", "was", "derived", "from", "an", "established", "tumor", "necrosis", "factor-alpha", "(", "TNF-alpha", ")", "inhibitor", "(", "Canventol", ")", "by", "replacement", "of", "the", "isopropylidine", "group", "with", "a", "phenyl", "ring", "."], "sentence": "The small molecule S9a was derived from an established tumor necrosis factor-alpha ( TNF-alpha ) inhibitor ( Canventol ) by replacement of the isopropylidine group with a phenyl ring .", "event_mentions": [], "entity_mentions": [{"id": "T2", "text": "tumor necrosis factor-alpha", "entity_type": "Protein", "start": 9, "end": 11}, {"id": "T3", "text": "TNF-alpha", "entity_type": "Protein", "start": 13, "end": 13}]}
{"doc_id": "PMID-9715838.txt", "sent_id": "", "tokens": ["S9a", "at", "10", "to", "100", "nM", "inhibited", "HIV", "production", "as", "potently", "as", "3'-azido-3'-deoxythymidine", "(", "AZT", ")", ",", "an", "inhibitor", "of", "viral", "reverse", "transcriptase", "."], "sentence": "S9a at 10 to 100 nM inhibited HIV production as potently as 3'-azido-3'-deoxythymidine ( AZT ) , an inhibitor of viral reverse transcriptase .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-9715838.txt", "sent_id": "S4", "tokens": ["Furthermore", ",", "S9a", "and", "AZT", "in", "combination", ",", "at", "noncytoxic", "concentrations", "strongly", "inhibited", "HIV-1", "replication", "that", "was", "more", "than", "additive", "and", "substantially", "prolonged", "the", "appearance", "of", "virus", "both", "in", "acutely", "infected", "CD4", "+", "lymphocytes", "(", "SupT", ")", "in", "culture", "and", "in", "peripheral", "blood", "mononuclear", "cells", "(", "PBMCs", ")", "infected", "with", "a", "primary", "HIV-1", "isolate", "."], "sentence": "Furthermore , S9a and AZT in combination , at noncytoxic concentrations strongly inhibited HIV-1 replication that was more than additive and substantially prolonged the appearance of virus both in acutely infected CD4 + lymphocytes ( SupT ) in culture and in peripheral blood mononuclear cells ( PBMCs ) infected with a primary HIV-1 isolate .", "event_mentions": [], "entity_mentions": [{"id": "T4", "text": "CD4", "entity_type": "Protein", "start": 31, "end": 31}]}
{"doc_id": "PMID-9715838.txt", "sent_id": "S5", "tokens": ["S9a", "inhibited", "TNF-alpha", "promoter", "-", "driven", "reporter", "gene", "activity", "."], "sentence": "S9a inhibited TNF-alpha promoter - driven reporter gene activity .", "event_mentions": [], "entity_mentions": [{"id": "T5", "text": "TNF-alpha", "entity_type": "Protein", "start": 2, "end": 2}]}
{"doc_id": "PMID-9715838.txt", "sent_id": "S6", "tokens": ["It", "was", "proposed", "that", "the", "mechanism", "of", "antiviral", "action", "of", "S9a", "was", "on", "the", "host", "cell", ",", "by", "blocking", "TNF-alpha", "transcription", "via", "a", "Tat", "-", "induced", "tar", "-", "independent", "loop", ",", "which", "decreases", "downstream", "NF-kappaB", "activation", "of", "HIV-1", "long", "terminal", "repeat", "(", "LTR", ")", "."], "sentence": "It was proposed that the mechanism of antiviral action of S9a was on the host cell , by blocking TNF-alpha transcription via a Tat - induced tar - independent loop , which decreases downstream NF-kappaB activation of HIV-1 long terminal repeat ( LTR ) .", "event_mentions": [{"id": "E2", "event_type": "Negative_regulation", "trigger": {"text": "blocking", "start": 18, "end": 18}, "arguments": [{"entity_id": "T10", "text": "transcription", "role": "Theme"}]}, {"id": "E3", "event_type": "Transcription", "trigger": {"text": "transcription", "start": 20, "end": 20}, "arguments": [{"entity_id": "T6", "text": "TNF-alpha", "role": "Theme"}]}, {"id": "E4", "event_type": "Positive_regulation", "trigger": {"text": "via", "start": 21, "end": 21}, "arguments": [{"entity_id": "T10", "text": "transcription", "role": "Theme"}, {"entity_id": "T12", "text": "induced", "role": "Cause"}]}, {"id": "E5", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 25, "end": 25}, "arguments": [{"entity_id": "T9", "text": "blocking", "role": "Theme"}, {"entity_id": "T7", "text": "Tat", "role": "Cause"}]}], "entity_mentions": [{"id": "T6", "text": "TNF-alpha", "entity_type": "Protein", "start": 19, "end": 19}, {"id": "T7", "text": "Tat", "entity_type": "Protein", "start": 23, "end": 23}, {"id": "T9", "text": "blocking", "entity_type": "Negative_regulation", "start": 18, "end": 18}, {"id": "T10", "text": "transcription", "entity_type": "Transcription", "start": 20, "end": 20}, {"id": "T11", "text": "via", "entity_type": "Positive_regulation", "start": 21, "end": 21}, {"id": "T12", "text": "induced", "entity_type": "Positive_regulation", "start": 25, "end": 25}]}
{"doc_id": "PMID-9715838.txt", "sent_id": "", "tokens": ["S9a", "was", "superior", "to", "the", "first", "generation", "compound", "Canventol", ",", "which", "was", "superior", "to", "the", "natural", "compound", "sarcophytol", "A", ",", "demonstrating", "that", "further", "structure-based", "enhancement", "of", "potency", "of", "these", "compounds", "is", "feasible", "."], "sentence": "S9a was superior to the first generation compound Canventol , which was superior to the natural compound sarcophytol A , demonstrating that further structure-based enhancement of potency of these compounds is feasible .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-9715838.txt", "sent_id": "", "tokens": ["This", "study", "suggests", "a", "therapeutic", "approach", "against", "AIDS", "by", "application", "of", "two", "drugs", ",", "one", "against", "a", "cellular", "and", "the", "other", "a", "viral", "target", ",", "which", "may", "provide", "an", "approach", "to", "the", "problem", "of", "frequent", "emergence", "of", "resistant", "variants", "to", "combinations", "of", "drugs", "that", "target", "only", "HIV", "genes", "."], "sentence": "This study suggests a therapeutic approach against AIDS by application of two drugs , one against a cellular and the other a viral target , which may provide an approach to the problem of frequent emergence of resistant variants to combinations of drugs that target only HIV genes .", "event_mentions": [], "entity_mentions": []}
